[go: up one dir, main page]

KR920012112A - 저온살균된 철-비함유 사람 트란스페린의 제조방법 및 이의 용도 - Google Patents

저온살균된 철-비함유 사람 트란스페린의 제조방법 및 이의 용도 Download PDF

Info

Publication number
KR920012112A
KR920012112A KR1019910022718A KR910022718A KR920012112A KR 920012112 A KR920012112 A KR 920012112A KR 1019910022718 A KR1019910022718 A KR 1019910022718A KR 910022718 A KR910022718 A KR 910022718A KR 920012112 A KR920012112 A KR 920012112A
Authority
KR
South Korea
Prior art keywords
transferrin
iron
human transferrin
complexing agent
free human
Prior art date
Application number
KR1019910022718A
Other languages
English (en)
Other versions
KR100224518B1 (en
Inventor
하우프트 하인쯔
Original Assignee
슈타인, 부크
베링베르케 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 슈타인, 부크, 베링베르케 아크티엔게젤샤프트 filed Critical 슈타인, 부크
Publication of KR920012112A publication Critical patent/KR920012112A/ko
Application granted granted Critical
Publication of KR100224518B1 publication Critical patent/KR100224518B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Manufacture Of Iron (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

내용 없음

Description

저온살균된 철-비함유 사람 트란스페린의 제조방법 및 이의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 착화제를 함유하는 사람의 트란스페린 용액을 저온살균함을 포함하여 사람의 트란스페린을 후처라하는 방법.
  2. 제1항에 있어서, 가용성 시트레이트 또는 에틸렌디아민테트라아세트삼(EDTA0의 염이 착화제로서 사용되는 방법.
  3. 제1항에 있어서, 트란스페린으로부터 착화제를 결합된 철과 함께 제거하는 방법.
  4. 제3항에 청구된 바와 같이 저온살균된, 철을 함유하지 않는 사람의 트란스페린.
  5. 약제로서의 제4항에서 청구된 사람의 트란스페린.
  6. 제4항에서 청구된 사람의 트란스페린의 성장인자로서의 용도.
    ※ 참고사항: 최초출원 내용에 의하여 공개되는 것임.
KR1019910022718A 1990-12-13 1991-12-12 Process for the production of pasteurized and iron-free human transferring and its use KR100224518B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4039721A DE4039721A1 (de) 1990-12-13 1990-12-13 Verfahren zur herstellung eines pasteurisierten und eisenfreien human-transferrins und seine verwendung
DEP4039721.1 1990-12-13

Publications (2)

Publication Number Publication Date
KR920012112A true KR920012112A (ko) 1992-07-25
KR100224518B1 KR100224518B1 (en) 1999-10-15

Family

ID=6420174

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910022718A KR100224518B1 (en) 1990-12-13 1991-12-12 Process for the production of pasteurized and iron-free human transferring and its use

Country Status (13)

Country Link
US (1) US5252715A (ko)
EP (1) EP0490384B1 (ko)
JP (1) JP3143507B2 (ko)
KR (1) KR100224518B1 (ko)
AT (1) ATE125303T1 (ko)
AU (1) AU656543B2 (ko)
CA (1) CA2057493C (ko)
DE (2) DE4039721A1 (ko)
DK (1) DK0490384T3 (ko)
ES (1) ES2075316T3 (ko)
GR (1) GR3017106T3 (ko)
IE (1) IE67791B1 (ko)
PT (1) PT99778B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0696455A1 (en) 1994-08-11 1996-02-14 Cellena (Cell Engineering) A.G. Transferrin compositions to alleviate the side effects of cytotoxic drugs
US6326473B1 (en) 1998-12-30 2001-12-04 Suomen Punainen Risti Veripalvelu Pharmaceutical preparations
US6251860B1 (en) * 1998-07-07 2001-06-26 Suomen Punainen Risti Veripalvelu Pharmaceutical preparations
JP2003517276A (ja) * 1998-11-30 2003-05-27 アイ・ブイ・エフ・サイエンシイズ・コロラド・インコーポレーテツド 体外受精のための系及び連続的培養液
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
WO2003086272A2 (en) * 2002-04-16 2003-10-23 Kamada Ltd. Ultrapure transferrin for pharmaceutical compositions
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
AR106418A1 (es) * 2015-10-26 2018-01-10 Linco Food Systems As Un método, un montaje de guía y un sistema para la separación de conjuntos de vísceras evisceradas de aves sacrificadas
CN111138524B (zh) * 2018-11-02 2023-07-07 武汉禾元生物科技股份有限公司 一种从基因工程水稻种子中分离纯化低铁饱和度的重组人乳铁蛋白的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4841026A (en) * 1987-01-27 1989-06-20 Miles Laboratories, Inc. Virally inactivated, non-toxic, human transferrin preparation
DE3733181C1 (de) * 1987-10-01 1989-01-19 Biotest Pharma Gmbh Verfahren zur Herstellung eines hochreinen,virussicheren,biologisch aktiven Transferrinpraeparates

Also Published As

Publication number Publication date
PT99778B (pt) 1999-05-31
CA2057493C (en) 2002-01-08
ES2075316T3 (es) 1995-10-01
JPH04290900A (ja) 1992-10-15
DE4039721A1 (de) 1992-06-17
ATE125303T1 (de) 1995-08-15
IE914330A1 (en) 1992-06-17
AU656543B2 (en) 1995-02-09
DE59106032D1 (de) 1995-08-24
EP0490384A1 (de) 1992-06-17
KR100224518B1 (en) 1999-10-15
IE67791B1 (en) 1996-04-17
PT99778A (pt) 1992-12-31
AU8962191A (en) 1992-06-18
EP0490384B1 (de) 1995-07-19
CA2057493A1 (en) 1992-06-14
US5252715A (en) 1993-10-12
JP3143507B2 (ja) 2001-03-07
GR3017106T3 (en) 1995-11-30
DK0490384T3 (da) 1995-11-13

Similar Documents

Publication Publication Date Title
ATE71820T1 (de) Innere prothese zum ersetzen eines menschlichen koerperteils, insbesondere fuer die gefaesschirurgie.
GB2276086A (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
FR2630115B1 (fr) Procede de stabilisation des solutions d'albumine humaine et solution obtenue
DE69120430D1 (de) Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE68919358D1 (de) Zusammensetzung zur behandlung der schizophrenie.
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
FR2350795A1 (fr) Procede de chauffage homogene, en particulier pour la sterilisation ou la conservation de denrees alimentaires contenant de l'eau, et dispositif pour son execution
FR2523956B1 (ko)
KR920012112A (ko) 저온살균된 철-비함유 사람 트란스페린의 제조방법 및 이의 용도
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
KR930009612A (ko) 바이러스-유리된 트롬빈 농축물 제조방법
DE69104083D1 (de) Neue Antiulcus-Substanz.
HUT61199A (en) Process for producing pharmaceutical compositions suitable for treating hyperlipidaemia and/or atherosclerosis
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
GB2210246B (en) Food product
PT75533A (fr) Procede de preparation de derives de phenoxy-3 propanol-2 et de compositions pharmaceutiques les contenant
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
GR3017967T3 (en) Substituted pyrido-oxazines.
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
KR890001540A (ko) 심부전증 치료제
KR900017599A (ko) 종양 치료용 약학 조성물
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
KR970019821A (ko) 송진을 함유한 치약 제조 방법
DE69210635D1 (de) Fosfomycin-Cetyltrimethylammonium-Salz und diese enthaltende Zusammensetzung für die lokale Behandlung von Vagina- und Harnröhre-Infektionen

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19911212

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19960830

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19911212

Comment text: Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 19980217

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19981104

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19990430

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19990714

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19990715

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20020626

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20030708

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20040709

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20050711

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20060711

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20070710

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20080701

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20090708

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20100712

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20100712

Start annual number: 12

End annual number: 12

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20120609